
The science behind Simtriyo, the first ADHD medication to target three major neurotransmitters
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOTFVIQXh5QnNPUWREWFU0dC12SlBLS2F4NFVUajBpbjhuNVhMdkhjYWhMd05reWN2SE1RYzQ2MlljME5wVU1uRGZ4WXN4ZzdUMVhBU3AySnByNDJnZXZOeE5Zei1wQmtYZXoxZVhSQkZIYTJUS3NFUWVGWUhsZGQ5UWg0R1o4VVAtT1hLSW5uYTBtMDdqRDd0STliTjdXMDNUNmVhOXRjaGFnWnNjMldJdWF4LW5IWmxHUkE?oc=5" target="_blank">The science behind Simtriyo, the first ADHD medication to target three major neurotransmitters</a>&nbsp;&nbsp;<font color="#6f6f6f">PsyPost</font>
